Description
Taylor & Francis Inc Atypical Antipsychotics by John C. Csernansky , John Lauriello
Showcasing the latest studies in the field, this reference unveils recent breakthroughs in the use of atypical antipsychotics for the treatment of a variety of patient populations-tracking developments in the management of patients with schizophrenia and affective psychotic disorders, as well as therapeutic regimens for children and adolescents. Atypical Antipsychotic Drugs: Theories of Mechanism of Action Scott Filippino and John G. Csernansky; Probing the "Receptorsome" Unveils the Receptor Pharmacology of Atypical Antipsychotic Drugs Bryan L. Roth; Neurophysiological Effects of Atypical Antipsychotic Drugs Patricio O'Donnell; Behavioral Models of Atypical Antipsychotic Drug Action in Rodents Mark E. Bardgett; Metabolic Regulation and Atypical Antipsychotic Drugs Pierre Chue; The Nosology of Psychosis: Schizophrenia, Affective Psychotic Disorders, and Drug-Induced Psychotic Disorders John Lauriello; Acute Efficacy of Atypical Antipsychotic Drugs Steve Marder; Long-Term Efficacy of Atypical Antipsychotic Drugs Robert Conley; Assessing the Effects of Atypical Antipsychotics on the CNS Utilizing Neuroimaging Juan Bustillo; Use of Atypical Antipsychotic Drugs in Children and Adolescents Peter Buckley; Use of Atypical Antipsychotic Drugs for the Treatment of Affective Disorders Martha Sajatovic; New Approaches to Drug Development Donald C. Goff; Index